Recipient
|
Department
|
Proposal Title
|
| Uri Barnea |
Marketing |
The effects of message ephemerality on communicators |
| Joshua Becker |
Annenberg School for Communications |
Can social influence improve financial forecasting? |
| T. Bradford Bitterly |
OID |
Humorous deflection |
| Edward Chang |
OID |
Testing an online intervention to reduce gender bias in the workplace |
| Yupeng Chen |
Marketing |
Can films improve the performance of referral programs by inducing reciprocity from customers? Evidence from a field experiment |
| Amanda Chuan |
Business Economics & Public Policy |
Labor Market Outcomes and the Reverse Gender Gap in College Enrollment |
| Youran Fu |
Business Economics & Public Policy |
Using social data to inform color inventory decision making |
| Celia Gaertig |
OID |
The wisdom of the inner crowd |
| Qing Gong |
Economics |
Physician learning and decision making: evidence from treatment choices for brain aneurysms |
| Zheng Huang |
Applied Economics |
Motivated Beliefs and Transaction Utility: Effects of Pricing Format on Willingness to Pay |
| Polly Kang |
Management |
The Effect of Shared Experience on Anger |
| Brooke Kelly |
Marketing |
Prosocial conflicts of interest |
| Elissa Kranzler |
Annenberg School for Communication |
Harnessing the power of a ‘neural focus group’ to predict population-level anti-smoking message effects on risky decisions among adolescents |
| Joshua Lewis |
OID |
Extremeness aversion in estimation |
| Robert Mislavsky |
OID |
Integrating non-quantitative quality and outcome judgments |
| Sam Skowronek |
OID |
The impact of reminders on prescription pickup |
| Shalena Srna |
Marketing |
When modesty pays |
| Basima Tewfik |
Management |
“My doctor’s an impostor!”:understanding the positive interpersonal outcomes of experiencing the impostor phenomenon |
| Esther Uduehi |
Marketing |
Obesity identity labeling: outside looking in, inside looking forward |
| Vanitha Virudachalam |
OID |
Optimizing performance pay in K-12 education |
| Ozge Yapar |
OID |
Bayesian bandits for sequential clinical trials of multiple technologies |
|
